Sun Pharma posts profit dive on U.S. pricing pressure | Reuters

REUTERS - India’s largest drugmaker Sun Pharmaceutical Industries reported a 59 percent plunge in second-quarter profit on Tuesday, hurt by generics pricing pressure in the United States. A logo of Sun Pharmaceutical Industries Ltd is pictured at its research and development center in Mumbai, India, December 21, 2015. REUTERS/Shailesh Andrade/FilesAlong with other Indian drugmakers, Sun Pharma has had sales dented by rising competition in the generics market and greater pricing scrutiny in the United States, though its quarterly results still beat analyst expectations. Sun Pharma Managing Director Dilip Shanghvi cited the pricing environment for the second-quarter profit fall but said results had also been hit by the company’s continued investment in its speciality drugs business. Profit came in at 9.12 billion rupees ($139.5 million) in the three months to Sept. 30, compared with 22.35 billion rupees a year ago, the company said ( Analysts had expected a profit of 8.27 billion rupees, Thomson Reuters data shows. Sun Pharma has also faced challenges in obtaining clearance for key factories under U.S. supply bans because of quality control issues. U.S. sales for the quarter fell 44 percent to $309 million while sales from India rose 11 percent. ($1 = 65.3850 Indian rupees)

This story has not been edited by Firstpost staff and is generated by auto-feed.

Updated Date: Nov 14, 2017 22:11 PM

Also Watch

Watch: Firstpost test rides the new Thunderbird 500X in Goa and walks you through the Royal Enfield Garage Cafe
  • Tuesday, April 17, 2018 Varun Dhawan on Shoojit Sircar's October, 5-star reviews and working with Anushka Sharma in Sui Dhaaga
  • Saturday, April 14, 2018 Ambedkar Jayanti: Re-visiting Babasaheb's ideals exposes fake Dalit politics of Rahul Gandhi and Congress
  • Monday, April 9, 2018 48 hours with Huawei P20 Pro: Triple camera offering is set to redefine smartphone imaging
  • Monday, April 16, 2018 Rajyavardhan Singh Rathore interview: Sports can't be anyone's fiefdom, we need an ecosystem to nurture raw talent

Also See